6/13 UWorld Flashcards

1
Q

Describe the pathophysiology of aortic aneurysm in syphilis

A

Tertiary syphilis begins with vaso vasorum endarteritis and obliteration, resulting in inflammation, ischemia, and weakening of the adventitia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the compenents of crescents in rapidly progressive glomerulonephritis

A

Fibrin and macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the equation for number needed to treat?

A

1/ARR

  • Absolute risk reduction (ARR)
    • Looking at how much a beneficial intervention (rather than a risk factor) will affect the risk of disease
      • Risk of those not receiving intervention minus risk of those receiving intervention
    • Equation:
      • ARR = [c/(c+d)] - [a/(a+b)]
      • THINK: ARR = NPV – PPV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the equation for relative risk

A
  • Probability of getting disease in exposed group vs. probability of getting disease in unexposed
    • Calculated from cohort studies
  • Equation:
    • RR = [a/(a+b)] / [c/(c+d)]
  • Remember that it is a ratio! Not subtraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Equation for odds ratio

A
  • Odds that group with disease (case) was exposed to a risk factor vs. odds that group without disease (control) was exposed
    • Calculated from case-control studies
  • Equation:
    • OR = [(a/c) / (b/d)] = ad/bc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Equation for relative risk reduction

A
  • The proportion of risk reduction attributable to the intervention as compared to a control
  • Equation:
    • RRR = 1 – RR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Equation for attributable risk

A
  • Difference in risk among exposed and risk among unexposed
  • Equation:
    • [a/(a+b)] – [c/(c+d)]
  • Same as relative risk, but subtraction instead of division
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What pathogens cause ring enhancing lesions in the brain

A

Toxoplasmosis

CNS lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where are enhancers/silencers located in reference to the gene they are working on (upstream, downstream

A

Can be located upstream, downstream, close to, far from, or even within (in an intron) the gene they are regulating

Vs. promoters which must be upstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What type of HSR is hyperacute (minutes) transplant rejection

A

Type II HSR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Reverse transcription polymerase chain reaction is used to detect levels of what in a sample?

A

mRNA

RT-PCR used the sample mRNA to produce complementary DNA that can be amplified by PCR

Because cDNA is complementary to mRNA, it contains exons and any untranslated regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe gram to calorie ratios for:

  • Protein
  • Carbohydrates
  • Fat
  • Ethanol
A

Protein = 4 cal/g

Carbs = 4 cal/g

Fat = 9 cal/g

Ethanol = 7 cal/g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Does oxygenated blood from mother to fetus come from the umbilical artery or umbilical vein

A

Vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What disease presents with diffuse ST segment elevation in all EKG leads

A

Pericarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Do first generation antipsychotics treat positive or negative sx of Schizoprenia

A

Positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the mechanism behind increased risk of TB in silicosis

A

Impaired phagolysosome formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the presentation of neurofibromatosis type 1

A
  • Neurocutaneous disorder characterized by café-au-lait spots, cutaneous neurofibromas, optic gliomas, pheochromocytomas, Lisch nodules (pigmented iris hamartomas)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe presentation of neurofibromatosis type 2

A
  • Bilateral acoustic schwannomas, juvenile cataracts, meningiomas, and ependymomas
  • Presentation:
    • Hearing loss, tinnitus, balance problems, hyperpigmented skin lesions, cataracts
  • REMEMBER 2’s:
    • Chr 22
    • Bilateral hearing loss
    • NF Type 2
    • Cataracts
21
Q

Mode of transmission of Hepatitis A

A

Travel to endemic areas

Contaminated water supply

Shellfish

22
Q

Mode of transmission of Hepatitis C

A

Exposure to infected blood

Sexual (less likely than Hep B to be transmitted this way)

23
Q

What anti-arrhythmic drug prolongs the QT interval but is associated with lower risk of torsade de pointes than the other QT-prolonging agents

A

Amiodarone

Other QT prolonging agent = Class IA (Procainamide, Quinidine, Disopyramide)

24
Q

What is a classic XR finding in Bacillus anthracis

A

Mediastinal widening

25
Q

What is unique about the capsule of Bacillus anthracis

A

It contains a D-glutamate capsule (remember poly-D) instead of polysaccharide

26
Q

What is the mutation associated with Lynch syndrome

A

MSH2, MLH1 – DNA mismatch repair

Not associated with APC mutation - recall that Lynch syndrome is hereditary nonpolyposis colon cancer (HNPCC)

27
Q

Symptoms of Parkinson’s

A
  • TRAPS + mask-like facies
    • Tremor (resting)
    • Rigidity (cogwheel)
    • Akinesia (or bradykinesia)
    • Postural instability
    • Staggering gait
28
Q

What adverse effects are likely to persist after adding carbidopa to levodopa

A

Carbidopa decreases peripheral conversion and enhances central converson of L-DOPA to DA

Will have more central side effects - anxiety and agitation

29
Q

What are the peripheral side effects of levadopa that are decreased with Carbidopa

A
  • Nausea and vomiting due to chemoreceptor stimulation
    • à nauseated hostage
  • Cardiac arrhythmias
    • à arrhythmia rope tying up the female hostage
  • Orthostatic hypotension
    • à female hostage passed out
30
Q

Where is the SA node located

A

R atrium near the opening of the SVC

31
Q

Where is the AV node located

A

RA near the septal cusp of the tricuspid valve

32
Q

What disease is associated with anti-mitochondrial antibodies

A

Primary biliary cirrhosis

33
Q

What antibody is associated with polymyositis/dermatomyositis

A

Anti-jo-1

ANA

34
Q

Describe the role of Cyclin D in cell replication

A

o Cyclin D activates CDK4 (kinase complex)

o This kinase complex will phosphorylate Rb protein

o Phosphorylated Rb becomes unbound from transcription factor E2F, allowing cell to progress from G1 to S phase

35
Q

Describe function of RAS (as an oncogene or tumor suppressor) + associated cancers

A
  • Oncogene = is a signal transducer (GTP-binding protein)
    • Ras is associated with growth factor receptors in an inactive GDP-bound state
    • Receptor binding causes GDP to be replaced with GTP, activating Ras
    • Activated Ras sends growth signals to the nucleus
    • Ras inactivates itself by cleaving GTP to GDP via GTPase protein
    • Mutated Ras inhibits the activity of GTPase, thus producing a prolonged activated state of Ras
  • Most common oncogene abnormality
  • Associated with:
    • o Pancreatic adenocarcinoma
    • o Cholangiocarcinoma
36
Q

Name the oncogene and the tumor suppressor associated with breast cancer

A

Oncogene = HER2 (EGFR)

Tumor suppressor = BRCA1/2

37
Q

What cancer will be CA 19-9+

A

Pancreatic cancer

38
Q

What cancers will be CEA+

A
  • CEA – carcinoembryonic antigen
    • § Colon cancer
    • § Pancreatic cancer
39
Q

What cancers will be AFP+

A

§ Hepatocellular carcinoma

§ Hepatoblastoma

§ Yolk sac tumor

§ Mixed germ cell tumor

40
Q

What cancers will be b-hCG+

A

§ Hydatidiform mole

§ Choriocarcinoma

§ Testicular cancer

§ Mixed germ cell tumor

41
Q

What cancers will be S-100+

A
  • o S-100 – Neural crest marker
    • § Melanoma
    • § Schwannoma
42
Q

What cancers will be alkaline phosphatase+

A

§ Metastasis to bone

§ Biliary disease

§ Paget disease of the bone

43
Q

What tumors will have psammoma bodies

A

Papillary thyroid carcinoma

Serous papillary cystadenocarcinoma of the ovary

Mesothelioma

Meningioma

44
Q

What tumors secrete erythropoietin

A
  • Potentially Really High Hematocrit
    • Pheochromocytoma
    • Renal cell carcinoma
    • Hepatocellular carcinoma
    • Hemangioblastoma
45
Q

Describe the synthesis of the pyrimidine, thymidine

A
  • Glutamine + CO2 + ATP converted to carbamoyl phosphate via carbamoly phosphate synthetase II
  • Carbomoyl phosphate converted to orotic acid
  • Orotic acid converted to UMP via UMP synthase
  • UMP to UDP
  • UDP to dUDP via ribonucleotide reductase
  • dUDP to dUMP
  • dUMP methylated to dTMP via thymidilate synthase
    • THF is what provides the carbon needed for methylation (THF to DHF)
    • Thymidylate synthase catalyzes the transfer of methyl group
    • DHF gets converted back to THF via dihydrofolate reductase
    • THF is then re-methylated to continue the cycle
46
Q

MOA of Methotrexate

A
  • Folate analog that competitively and irreversibly binds to dihydrofolate reductase, preventing convserion of DHF into THF
  • Inhibition of DHF reductase leads to a build-up of DHF
  • This means you have no THF to create dTMP
    • Interferes with the synthesis of DNA, RNA, and other rapidly dividing cells
    • Rapidly dividing cells are the ones that are preferentially targeted
    • Most effective during S phase (when cells are undergoing synthesis of new DNA)
47
Q

How do you reverse the toxicity of methotrexate

A
  • Leucovorin (folinic acid – reduced form of folate)
      • lucky feline (cat statue)
  • Can be used to reverse the toxicity effects of MTX (“leucovorin rescue”)
  • Folinic acid does not require DHF reductase
48
Q

MOA of 5-Fluorouracil (5-FU)

A

5-FU is a cytotoxic pyrimidine analog

5-FU is metabolized by intracellular reaction to it’s active form FDuMP

FDUMP forms a complex with THF and inhibits thymidylate synthase (conversion of dUMP to dTMP using carbon from THF)

Inhibition of thymidylate synthase by 5-FU will lead to a build-up of dUMP

49
Q

MOA of hydroxyurea

A
  • Recall:
    • The precursor of all pyramidine nucelotides is UMP, which is then phosphorylated to UDP
    • Ribonucleotide reductase will convert UDP to dUDP
    • dUDP can then be de-phosphorylated into dUMP
  • Hydroxyurea works by inhibiting ribonucleotide reductase so that UDP cannot be converted to dUDP, thus blocking the de novo synthesis of thymidine